R-Pharm mentioned among anti-corruption compliance leaders in Russia

June 4

According to the latest Transparency in corporate reporting 2017 research conducted by Transparency international in Russia, R-Pharm was acknowledged as one of the leaders in anti-corruption documentation category (14th place overall and 1st in Russian pharmaceutical industry).

R-Pharm states combat against corruption and bribery in any form among its principal goals. Systemic approach and sincere dedication of all employees help company to establish honest and transparent business atmosphere, eliminate any possibility of illicit conduct.

In order to make this combat even more efficient R-Pharm implements a wide range of compliance and ethics related documents such as Code of business conduct, Anti-corruption policy, Anti-monopoly policy, Commercial policy etc. Various operational procedures are used to ensure that company’s business and charity activities are in complete accordance with existing laws and international standards. All documents are published on the corporate site.

R-Pharm employees undergo several trainings per year in order to improve their knowledge of compliance procedures. Every contractor is expected to comply with R-Pharm’s rigorous standards.

The company is dedicated to continuously strengthen its business transparency and implement policy of zero tolerance towards corruption.

Other company news

06 November 2018 – R-Pharm Group and the Specialty Pharma Company PAION AG (ISIN DE000A0B65S3; Frankfurt Stock Exchange Prime Standard:...
read more...
November 6
The IV Eurasian Rheumatology Congress attended by leading healthcare professionals from around the globe was held in Moscow on 26-28...
read more...
September 28
Localization of full cycle production of Kaletra® finished dosage form will help to improve access of Russian patients to antiretroviral...
read more...
July 4